Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Hepatology. 2009 Sep;50(3):799–807. doi: 10.1002/hep.23054

Fig. 1.

Fig. 1.

NK cell cytotoxicity is reduced in patients with HCC. NK cells were FACS-sorted from PBMCs of either healthy donors (n = 10) or patients with HCC (n = 10), or from tumor-infiltrating lymphocytes (n = 5) by gating on CD56+CD3− population and used in a 51Cr-release assay against K562 target cells. Figure shown is average of four independent experiments (*P < 0.05).